secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001104659-23-101975
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical regains Nasdaq equity compliance after $19M Maruho license
--------------------------------------------------------------------------

- Previously disclosed Nasdaq Staff notified Company of non-compliance with $2.5M stockholders' equity requirement on August 15, 2023.
- On August 31, 2023, entered exclusive license agreement with Maruho for Qbrexza; Maruho paid $19M.
- Company now believes it satisfies Stockholders' Equity Requirement and awaits formal Nasdaq determination.
- Company had deadline of September 29, 2023 to submit compliance plan if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923101975/0001104659-23-101975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923101975/tm2326458d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-101975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer